Janssen competitors

Zippia score 4.9

Janssen main competitors are Boehringer Ingelheim, Bristol-Myers Squibb, and Allergan plc.

Competitor Summary. See how Janssen compares to its main competitors:

Sanofi US has the most employees (110,000).
Employees at Boehringer Ingelheim earn more than most of the competitors, with an average yearly salary of $106,981.

Work at Janssen?

Share your experience

Janssen vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Janssen	1953	4.9	Raritan, NJ	4	$601.4M	1,500
CHADD	1987	3.4	Lanham, MD	1	$2.0M	19
Endo Pharmaceuticals Inc	1997	4.7	Malvern, PA	3	$2.6B	385
Boehringer Ingelheim	1984	4.6	Ridgefield, CT	5	$17.2B	52,391
Daiichi Sankyo	2005	4.8	Parsippany-Troy Hills, NJ	2	$9.0B	15,348
PDI	1987	4.4	Parsippany-Troy Hills, NJ	1	$22.0M	350
Warner Chilcott	1968	4.2	Rockaway, NJ	1	$105.1M	3,000
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
Organon	-	4.5	-	-	$6.4B	158
UCB	1928	4.3	Smyrna, GA	3	$5.7B	7,600
Bristol-Myers Squibb	1887	4.6	New York, NY	13	$48.3B	30,000
Allergan plc	1948	4.8	Irvine, CA	1	$7.2B	11,400
Forest Pharmaceuticals Inc	1954	4.2	Saint Louis, MO	1	$40.0M	50
Noven	1987	4.6	Miami, FL	2	$520.0M	586
Takeda Pharmaceuticals U.S.A., Inc.	1998	4.7	Deerfield, IL	14	$12.1B	30,481
Sanofi US	1973	4.3	Bridgewater, NJ	1	$980.0M	110,000
Pharmacia	1901	4.3	Kalamazoo, MI	1	$130.0M	350
Depomed	1995	4.0	Newark, CA	2	$342.7M	494
Purdue Pharma L.P.	1892	4.9	Stamford, CT	2	$3.0B	5,000
Glaxosmithkline	2000	4.6	Philadelphia, PA	8	$34.1B	99,000
KV Pharmaceutical	1942	4.1	Chesterfield, MO	1	$91.0M	7,500

Rate how well Janssen differentiates itself from its competitors.

Janssen salaries vs competitors

Among Janssen competitors, employees at Boehringer Ingelheim earn the most with an average yearly salary of $106,981.

Compare Janssen salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Janssen	$96,292	$46.29	-
CHADD	$44,154	$21.23	-
Endo Pharmaceuticals Inc	$78,978	$37.97	-
Boehringer Ingelheim	$106,981	$51.43	-
Daiichi Sankyo	$82,543	$39.68	-
PDI	$64,390	$30.96	-

Compare Janssen job title salaries vs competitors

Company	Highest salary	Hourly salary
Janssen	$211,916	$101.88
Noven	$341,808	$164.33
PDI	$328,580	$157.97
UCB	$326,806	$157.12
Depomed	$324,700	$156.11
Pharmacia	$324,381	$155.95
Organon	$323,292	$155.43
Daiichi Sankyo	$320,895	$154.28
Sanofi US	$315,851	$151.85
CHADD	$315,405	$151.64
Endo Pharmaceuticals Inc	$315,317	$151.59
Takeda Pharmaceuticals U.S.A., Inc.	$312,030	$150.01
Glaxosmithkline	$306,036	$147.13
Forest Pharmaceuticals Inc	$289,292	$139.08
Purdue Pharma L.P.	$286,344	$137.67
Warner Chilcott	$270,914	$130.25
KV Pharmaceutical	$266,338	$128.05
Allergan plc	$225,127	$108.23
Boehringer Ingelheim	$209,865	$100.90
Bristol-Myers Squibb	$182,138	$87.57

Do you work at Janssen?

Does Janssen effectively differentiate itself from competitors?

Janssen jobs

Janssen demographics vs competitors

Compare gender at Janssen vs competitors

Job title	Male	Female
Janssen	51%	49%
Daiichi Sankyo	51%	49%
Glaxosmithkline	52%	48%
Endo Pharmaceuticals Inc	52%	48%
Bristol-Myers Squibb	53%	47%
Merck	54%	46%

Male

Female

100%

75%

50%

25%

Merck

Bristol-Myers Squibb

Endo Pharmaceuticals Inc

Glaxosmithkline

Daiichi Sankyo

Janssen

25%

50%

75%

100%

Compare race at Janssen vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Janssen	57%	19%	9%	11%	3%	9.7
Bristol-Myers Squibb	55%	19%	10%	13%	3%	9.7
Merck	56%	16%	10%	14%	4%	9.8
Daiichi Sankyo	60%	15%	11%	10%	4%	9.5
Endo Pharmaceuticals Inc	60%	13%	12%	11%	4%	9.8
Glaxosmithkline	59%	13%	12%	12%	4%	9.8

Janssen and similar companies CEOs

CEOBio

Giovanni Caforio

Bristol-Myers Squibb

Dr. Caforio has been our Chief Executive Officer since May 2015. He was our Chief Executive Officer Designate from January to May 2015, our Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014. From October 2011 to November 2013, he served as President, U.S. He held the position of Senior Vice President, Global Commercialization and Immunology from May 2010 to October 2011. Prior to that, he served as Senior Vice President, Oncology, U.S. and Global Commercialization from March 2009 to May 2010. From January 2007 to March 2009 he served as Senior Vice President, U.S. Oncology and from May 2004 to January 2007, he served as Senior Vice President, European Marketing and Brand Commercialization. Dr. Caforio is a member of the Board of Trustees of Hun School of Princeton and a member of the Business Roundtable, CEO Roundtable on Cancer and the Pharmaceutical Research and Manufacturers of America (PhRMA) and The Prium.

Dan Peisert

Depomed

Robert M. Davis

Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Ken Keller

Daiichi Sankyo

Paul Campanelli

Endo Pharmaceuticals Inc

Emma N. Walmsley

Glaxosmithkline

Mark Morse

Pharmacia

Craig Landau

Purdue Pharma L.P.

Craig Landau is a President/CEO at Purdue Biopharma LP and President/CEO at PURDUE PHARMA and is based in Stamford, Connecticut. He has worked as Major at United States Army, Associate Medical Director at Knoll Pharmaceutical Co, and Executive Medical Director at PURDUE PHARMA. Craig attended WINTHROP-UNIVERSITY HOSPITAL between 1991 and 1992, Icahn School of Medicine at Mount Sinai between 1987 and 1991, and Yale University-School of Medicine between 1992 and 1995.

Paul Hudson

Sanofi US

Roger Boissonneault

Warner Chilcott